Urine test could reduce unnecessary prostate cancer biopsies
Unnecessary prostate cancer biopsies could be reduced by 60 per cent thanks to new research from the University of East Anglia.
Mar 10, 2020
0
249
Unnecessary prostate cancer biopsies could be reduced by 60 per cent thanks to new research from the University of East Anglia.
Mar 10, 2020
0
249
A method of testing for prostate cancer developed at the National Cancer Institute (NCI) leads to more accurate diagnosis and prediction of the course of the disease, according to a large study. This method, which combines ...
Mar 4, 2020
0
8
(HealthDay)—Men exposed to antidiabetic medications do not have different prostate-specific antigen (PSA) levels, and prostate cancer detection rates at biopsy do not differ regardless of trigger PSA levels, according to ...
Nov 7, 2019
0
2
Every year, tens thousands of men in the United States are diagnosed with low-risk prostate cancer. Most are told that they don't need treatment other than "active surveillance" to monitor their slow-growing tumors. Now, ...
Sep 16, 2019
0
31
A new and simple blood test has been found to efficiently and accurately detect the presence of aggressive prostate cancer, according to research by Queen Mary University of London.
Sep 10, 2019
0
2434
Using MRI scans to target biopsies is more effective at detecting prostate cancers that are likely to need treatment than standard ultrasound guided biopsies alone, according to research published in JAMA Network Open. The ...
Aug 13, 2019
0
10
Each year, 1 million men in the U.S. undergo biopsies to determine whether they have prostate cancer. The biopsy procedure traditionally has been guided by ultrasound imaging, but this method cannot clearly display the location ...
Jun 12, 2019
0
174
The Gale and Graham Wright Prostate Centre at North York General Hospital (NYGH) is advancing prostate cancer care with a new study that shows the benefits of transperineal prostate biopsies (TPBx) under local anesthetic.
May 9, 2019
0
2
A new technique for imaging of microbubble ultrasound contrast agents may be useful in detection of prostate cancer (PCa) not found by multiparametric magnetic resonance imaging (MRI), according to a study to be presented ...
May 6, 2019
0
1
(HealthDay)—Atenolol is associated with a reduction in incident intermediate- and low-risk prostate cancer (PCa), according to a study presented at the annual meeting of the American Urological Association, held from May ...
May 6, 2019
0
1